May 18, 2021
A new peer-reviewed study from Juul Labs found that found that while rates of complete switching from cigarettes to JUUL products among adult smokers who purchase JUUL products in the United Kingdom are encouraging, they are lower than switch rates among similar smokers in the United States and Canada, where higher nicotine concentration products are available.
April 27, 2021
Juul Labs’ Chief Regulatory Officer, Joe Murillo, published a piece entitled “Juul Labs: Advancing the Scientific Dialogue About Tobacco Harm Reduction” in the Food & Drug Law Institute (FDLI) newsletter.
April 26, 2021
This month we celebrate a significant milestone in our efforts to expand the body of evidence surrounding vapor products with the publication of 11 peer-reviewed studies in a monograph edition of the American Journal of Health Behavior (AJHB).
February 24, 2021
Juul Labs today announced findings from its science and research program at the 2021 Annual Meeting of the Society for Research on Nicotine & Tobacco (SRNT), which was held virtually.
August 18, 2020
Juul Labs today announced that it received notice from the Food and Drug Administration (FDA) that the company’s Premarket Tobacco Product Applications (PMTA) will enter the substantive review phase.
July 30, 2020
The company’s submission includes comprehensive scientific evidence for the JUUL Device and JUULpods in Virginia Tobacco and Menthol flavors at nicotine concentrations of 5.0% and 3.0%, as well as information on its data-driven measures to address underage use of its products.
August 20, 2019
We are fully committed to the current PMTA process and are confident in the content and quality of the materials we will submit with our application by…